“Prognostic Value of KRAS G12C in Advanced Non-Small Cell Lung Cancer With High PD-L1 Expression Treated With Upfront Immunotherapy: A Systematic Review and Meta-Analysis”. Swiss Medical Weekly, vol. 154, no. 7, July 2024, p. 3695, https://doi.org/10.57187/s.3695.